Editas Medicine, Inc.
EDIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -58.6% | 296.3% | -22.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 92.2% | 67.9% | 80.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -721.4% | -208.8% | -1,114.1% | -736.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -733.7% | -196.1% | -1,118.3% | -753.6% |
| EPS Diluted | -2.88 | -2.02 | -3.21 | -2.85 |
| % Growth | -42.6% | 37.1% | -12.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |